Spiperone

Spiperone
Clinical data
AHFS/Drugs.com	International Drug Names
Routes of; administration	Oral
ATC code	none;
Legal status
Legal status	Rx-only (JP);
Pharmacokinetic data
Metabolism	Hepatic
Excretion	Renal
Identifiers
	IUPAC name 8-[4-(4-fluorophenyl)-4-oxobutyl]-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one;
CAS Number	749-02-0 ;
PubChem CID	5265;
IUPHAR/BPS	99;
ChemSpider	5075 ;
UNII	4X6E73CJ0Q;
KEGG	D01051 ;
ChEBI	CHEBI:9233 ;
ChEMBL	ChEMBL267930 ;
CompTox Dashboard (EPA)	DTXSID5045205 ;
ECHA InfoCard	100.010.931
Chemical and physical data
Formula	C23H26FN3O2
Molar mass	395.478 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES c1ccc(cc1)N2CNC(=O)C23CCN(CC3)CCCC(=O)c4ccc(cc4)F;
	InChI InChI=1S/C23H26FN3O2/c24-19-10-8-18(9-11-19)21(28)7-4-14-26-15-12-23(13-16-26)22(29)25-17-27(23)20-5-2-1-3-6-20/h1-3,5-6,8-11H,4,7,12-17H2,(H,25,29) ; Key:DKGZKTPJOSAWFA-UHFFFAOYSA-N ;
	(verify)

Spiperone, also known as spiroperidol and sold under the brand name Spiropitan ((JP)) is a typical antipsychotic of the butyrophenone family related to haloperidol. It is approved for clinical use in Japan as a treatment for schizophrenia.